Prevalence and risk factors of elevated pulmonary artery pressures in adults with sickle cell disease

S. Elshazly, N. Abdelaty, K. Said, N. Heida (Cairo, Ismailia, Egypt)

Source: Annual Congress 2010 - Pulmonary circulation III
Session: Pulmonary circulation III
Session type: Thematic Poster Session
Number: 1140
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Elshazly, N. Abdelaty, K. Said, N. Heida (Cairo, Ismailia, Egypt). Prevalence and risk factors of elevated pulmonary artery pressures in adults with sickle cell disease. Eur Respir J 2010; 36: Suppl. 54, 1140

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prevalence of cardiovascular risk factors and coronary artery disease in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017

COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018



Prevalence, risk factors and clinical importance of pulmonary artery catheter induced thrombocytopenia
Source: Eur Respir J 2003; 22: Suppl. 45, 189s
Year: 2003

The prevalence and affecting factors of pulmonary hypertension in hemodialysis patients
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009

Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2011; 39: 112-118
Year: 2012



Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease
Source: Eur Respir J 2012; 39: 112-118
Year: 2012



Analysis of mortality risk factors in a population with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


The prevalence of pulmonary hypertension and the related factors in hemodialysis patients
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease
Source: Eur Respir J, 54 (6) 1900585; 10.1183/13993003.00585-2019
Year: 2019



COPD phenotypes not linked to increased risk of coronary heart disease
Source: International Congress 2019 – Comorbidities galore in respiratory patients
Year: 2019




Fibrinogen plasma levels and disease severity in pulmonary artery hypertension
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010

Prevalence of pulmonary arterial hypertension using doppler echocardiografic method in sickle cell disease
Source: Annual Congress 2007 - Pulmonary hypertension
Year: 2007


Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir Rev 2012; 21: 27-31
Year: 2012



Screening for pulmonary hypertension in sickle cell disease: A regional survey
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010


The frequency of chronic thromboembolic pulmonary hypertension and associated risk factors
Source: Annual Congress 2011 - Prediction of pulmonary thromboembolism
Year: 2011


Impact of age and comorbidity on risk stratification in idiopathic pulmonary arterial hypertension
Source: Eur Respir J, 51 (5) 1702310; 10.1183/13993003.02310-2017
Year: 2018



Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2012; 39: 3-4
Year: 2012


Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different
Source: Eur Respir J 2011; 39: 3-4
Year: 2012


Risk stratification of pulmonary arterial hypertension (PAH) associated with adult congenital heart disease (ACHD)
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019